
|Articles|March 31, 2008
Two HIV drugs suspected of producing higher cardiovascular risk
FDA is looking at whether Ziagen and Videx is linked to more heart attacks.
Advertisement
A study has found that abacavir (Ziagen, GlaxoSmithKline) and didanosine (Videx, Bristol-Myers Squibb) are associated with an increased risk of heart attack. So the Food & Drug Administration has issued an early
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Explaining COVID-19 Vaccine Side Effects to Anxious Patients
3
Expert Discusses Flu and COVID-19 Vaccine Guidance
4
AI, Automation Are Transforming Pharmacies into Proactive Care Hubs
5







































